Shanghai Kinetic Medical Co Ltd
SZSE:300326
Balance Sheet
Balance Sheet Decomposition
Shanghai Kinetic Medical Co Ltd
Current Assets | 1.7B |
Cash & Short-Term Investments | 1B |
Receivables | 268.1m |
Other Current Assets | 403.7m |
Non-Current Assets | 1.6B |
Long-Term Investments | 519.1m |
PP&E | 374.4m |
Intangibles | 668.1m |
Other Non-Current Assets | 84.4m |
Current Liabilities | 329.4m |
Accounts Payable | 67.5m |
Accrued Liabilities | 79.7m |
Short-Term Debt | 128.7m |
Other Current Liabilities | 53.4m |
Non-Current Liabilities | 164.8m |
Long-Term Debt | 53.7m |
Other Non-Current Liabilities | 111.1m |
Balance Sheet
Shanghai Kinetic Medical Co Ltd
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
321
|
210
|
465
|
327
|
1 046
|
826
|
695
|
723
|
703
|
615
|
|
Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
722
|
703
|
615
|
|
Cash Equivalents |
321
|
210
|
465
|
327
|
1 046
|
826
|
694
|
1
|
1
|
0
|
|
Short-Term Investments |
10
|
12
|
35
|
188
|
34
|
169
|
172
|
178
|
264
|
421
|
|
Total Receivables |
159
|
286
|
364
|
484
|
561
|
679
|
690
|
556
|
447
|
268
|
|
Accounts Receivables |
142
|
271
|
335
|
430
|
382
|
552
|
578
|
454
|
368
|
218
|
|
Other Receivables |
16
|
16
|
29
|
53
|
179
|
127
|
112
|
102
|
79
|
50
|
|
Inventory |
46
|
67
|
84
|
115
|
169
|
222
|
239
|
294
|
347
|
368
|
|
Other Current Assets |
5
|
10
|
6
|
31
|
35
|
24
|
27
|
45
|
62
|
35
|
|
Total Current Assets |
541
|
585
|
954
|
1 145
|
1 844
|
1 920
|
1 822
|
1 794
|
1 824
|
1 708
|
|
PP&E Net |
215
|
283
|
302
|
288
|
260
|
264
|
374
|
365
|
353
|
374
|
|
PP&E Gross |
215
|
283
|
302
|
288
|
260
|
264
|
374
|
365
|
353
|
374
|
|
Accumulated Depreciation |
42
|
69
|
91
|
112
|
124
|
148
|
214
|
227
|
279
|
325
|
|
Intangible Assets |
45
|
88
|
98
|
100
|
74
|
76
|
79
|
69
|
71
|
66
|
|
Goodwill |
347
|
615
|
615
|
1 008
|
1 226
|
1 228
|
910
|
750
|
594
|
602
|
|
Long-Term Investments |
156
|
68
|
96
|
128
|
140
|
253
|
395
|
449
|
495
|
519
|
|
Other Long-Term Assets |
9
|
57
|
152
|
26
|
26
|
29
|
101
|
82
|
76
|
84
|
|
Other Assets |
347
|
615
|
615
|
1 008
|
1 226
|
1 228
|
910
|
750
|
594
|
602
|
|
Total Assets |
1 313
N/A
|
1 696
+29%
|
2 217
+31%
|
2 695
+22%
|
3 570
+32%
|
3 770
+6%
|
3 681
-2%
|
3 510
-5%
|
3 412
-3%
|
3 354
-2%
|
|
Liabilities | |||||||||||
Accounts Payable |
19
|
22
|
22
|
64
|
84
|
99
|
100
|
111
|
98
|
68
|
|
Accrued Liabilities |
21
|
24
|
23
|
28
|
38
|
101
|
115
|
93
|
99
|
80
|
|
Short-Term Debt |
49
|
117
|
113
|
198
|
324
|
258
|
284
|
196
|
182
|
129
|
|
Current Portion of Long-Term Debt |
0
|
0
|
47
|
93
|
15
|
45
|
254
|
93
|
116
|
17
|
|
Other Current Liabilities |
45
|
40
|
30
|
46
|
143
|
157
|
166
|
75
|
49
|
37
|
|
Total Current Liabilities |
134
|
202
|
234
|
430
|
604
|
659
|
919
|
568
|
545
|
329
|
|
Long-Term Debt |
70
|
155
|
108
|
62
|
285
|
240
|
48
|
141
|
35
|
54
|
|
Deferred Income Tax |
4
|
9
|
9
|
9
|
3
|
10
|
4
|
9
|
9
|
15
|
|
Minority Interest |
51
|
149
|
3
|
15
|
3
|
4
|
44
|
45
|
75
|
89
|
|
Other Liabilities |
10
|
14
|
25
|
153
|
176
|
109
|
23
|
13
|
9
|
7
|
|
Total Liabilities |
268
N/A
|
528
+97%
|
378
-28%
|
668
+77%
|
1 071
+60%
|
1 022
-5%
|
1 038
+2%
|
776
-25%
|
673
-13%
|
494
-27%
|
|
Equity | |||||||||||
Common Stock |
176
|
352
|
715
|
716
|
720
|
723
|
723
|
720
|
717
|
717
|
|
Retained Earnings |
185
|
289
|
428
|
606
|
1 047
|
1 298
|
1 230
|
1 356
|
1 299
|
1 411
|
|
Additional Paid In Capital |
684
|
526
|
695
|
707
|
736
|
771
|
783
|
730
|
703
|
700
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
|
Treasury Stock |
0
|
0
|
0
|
0
|
0
|
87
|
61
|
32
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
1
|
3
|
43
|
33
|
47
|
14
|
26
|
|
Total Equity |
1 044
N/A
|
1 168
+12%
|
1 839
+57%
|
2 027
+10%
|
2 499
+23%
|
2 748
+10%
|
2 643
-4%
|
2 734
+3%
|
2 740
+0%
|
2 860
+4%
|
|
Total Liabilities & Equity |
1 313
N/A
|
1 696
+29%
|
2 217
+31%
|
2 695
+22%
|
3 570
+32%
|
3 770
+6%
|
3 681
-2%
|
3 510
-5%
|
3 412
-3%
|
3 354
-2%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
632
|
632
|
715
|
716
|
720
|
715
|
717
|
717
|
717
|
717
|